Comparison of Two Different Techniques for Isolated Left Subclavian Artery Revascularization During Thoracic Endovascular Aortic Repair in Zone 2

医学 主动脉修补术 血运重建 左锁骨下动脉 心脏病学 锁骨下动脉 外科 内科学 冲程(发动机) 主动脉 主动脉弓 心肌梗塞 机械工程 工程类
作者
Gabriele Piffaretti,Giovanni Pratesi,Guido Gelpi,Mario Galli,Frank J. Criado,Michele Antonello,Federico Fontana,Filippo Piacentino,Edoardo Macchi,Matteo Tozzi,Patrizio Castelli,Matteo Barbante,Arnaldo Ippoliti,Claudia Romagnoni,Carlo Antona,Anita Paggi,Andrea Xodo,Franco Grego
出处
期刊:Journal of Endovascular Therapy [SAGE Publishing]
卷期号:25 (6): 740-749 被引量:33
标识
DOI:10.1177/1526602818802581
摘要

Purpose: To analyze the results of isolated left subclavian artery (LSA) revascularization during thoracic endovascular aortic repair (TEVAR) using carotid-subclavian bypass (CSbp) or chimney grafts (CGs). Methods: A retrospective multicenter, observational study identified 73 patients (mean age 68±13 years, range 22–87; 56 men) with acute or chronic thoracic aortic lesions who underwent TEVAR with isolated LSA revascularization using either CSbp (n=42) or CGs (n=31) from January 2010 and February 2017. Primary endpoints were TEVAR-related mortality, postoperative stroke, freedom from type Ia endoleak, and LSA patency. Results: Primary technical success was achieved in all cases. Early TEVAR-related mortality was 4.2% (CSbp 2% vs CG 6%, p=0.571). Two (3%) patients had major ischemic strokes (one in each group). Mean follow-up was 24±21 months (range 1–72; median 15). Estimated freedom from TEVAR-related mortality was 93%±3% (95% CI 84.3% to 97.0%) at 12 and 36 months, with no significant difference between CSbp and CG (p=0.258). Aortic reintervention did not differ between the groups (CSbp 5% vs CG 6%, p=0.356); nor did freedom from type Ia endoleak (CSbp 98% vs CG 87%, p=0.134). Gutter-related endoleaks occurred in 4 (13%) CG patients, but none of the patients experienced sac enlargement or the need for reintervention and none died. Primary patency of the LSA was 100% for the entire group during the observation period. Conclusion: In our experience, LSA revascularization proved most satisfactory and equally effective with both the CSbp and CG techniques, without discernible differences at midterm follow-up.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yzz发布了新的文献求助10
刚刚
无风完成签到 ,获得积分10
刚刚
碧蓝的笙发布了新的文献求助10
1秒前
Gaoxiong完成签到,获得积分20
2秒前
2秒前
科研通AI6.1应助zhanghao采纳,获得10
2秒前
青寻完成签到,获得积分10
3秒前
3秒前
3秒前
minsu发布了新的文献求助10
3秒前
3秒前
椰青完成签到,获得积分10
4秒前
欸嘿发布了新的文献求助10
4秒前
4秒前
tanghong发布了新的文献求助50
4秒前
caigou发布了新的文献求助10
4秒前
Fayth完成签到,获得积分10
4秒前
遥想得山田完成签到,获得积分10
6秒前
852应助美好的菲音采纳,获得10
6秒前
6秒前
研友_VZG7GZ应助haozai201采纳,获得10
7秒前
饭团完成签到,获得积分10
7秒前
认真匪发布了新的文献求助10
7秒前
aab发布了新的文献求助10
8秒前
时光发布了新的文献求助10
8秒前
9秒前
小白完成签到 ,获得积分10
9秒前
9秒前
团宝妞宝完成签到,获得积分10
9秒前
12281w完成签到,获得积分20
9秒前
一颗松发布了新的文献求助10
9秒前
10秒前
10秒前
魔真人完成签到,获得积分10
10秒前
我爱读文献完成签到,获得积分10
11秒前
小mol仙完成签到,获得积分10
12秒前
qq发布了新的文献求助50
12秒前
顾矜应助饭团采纳,获得10
13秒前
李卷发布了新的文献求助10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
Social Work and Social Welfare: An Invitation(7th Edition) 410
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6053590
求助须知:如何正确求助?哪些是违规求助? 7873617
关于积分的说明 16278909
捐赠科研通 5198946
什么是DOI,文献DOI怎么找? 2781701
邀请新用户注册赠送积分活动 1764628
关于科研通互助平台的介绍 1646217